Sanofi and Innate Pharma team up for NKp46-bispecific NK cell engagers
11 January 2016 | By Victoria White
The companies will work together on the generation and evaluation of up to two bispecific NK cell engagers, using technology from Innate and Sanofi's proprietary bispecific antibody format as well as tumour targets...